Fortress Biotech and Cyprium Therapeutics alongwith Zydus��� Sentynl Therapeutics Announce CUTX-101, Copper Histidinate Data to be Presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting
Press Release Mar 21 2022
Filed with NSE · · 4 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Mar 14 2022
- Press Release Mar 09 2022
- Press Release Mar 08 2022
- Press Release Mar 07 2022
- Press Release Feb 23 2022
Later from Zydus Lifesciences
- Press Release Apr 01 2022
- Press Release Apr 13 2022
- Press Release Apr 18 2022
- Press Release Apr 25 2022
- Press Release Apr 26 2022
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences